����ϵ�y(t��ng)�[��

Biology of Urinary System Tumor Androgen receptor gene mutation, rearrangement, polymorphism Androgen receptor epigenetics Androgen receptor genomic regulation Decoding the androgen receptor splice variants Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation Novel non-AR therapeutic targets in castrate resistant prostate cancer Steroid hormone synthetic pathways in prostate cancer Translating insights of AR signaling from mouse models Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression The role of microRNAs in prostate cancer progression Cancer stem cells in prostate cancer Bacille-Calmette-Guerin non-responders: how to manage TGF-13 mediated DNA methylation in prostate cancer Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients Diagnostic Methods of Urinary System Tumor Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint The current and future role of magnetic resonance imaging in prostate cancer detection and management Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer Treatment of Urinary System Tumor Surgical Treatment of Urinary System Tumor Standard cystectomy fits all: truth or myth? Outlining the limits of partial nephrectomy Penile rehabilitation after radical prostatectomy: does it work? Cytoreductive surgery in the era of targeted molecular therapy Presentation, management, and outcomes of complications following prostate cancer therapy Chemotherapy of Urinary System Tumor Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer Beyond chemotherapy for advanced disease--the role of EGFR and PD-1 inhibitors Radiotherapy of Urinary System Tumor Radiotherapv for prostate cancer and sexual health Stereotactic body radiotherapy for organ-confined prostate cancer Proton beam radiation therapy of prostate cancer - history, results, and future directions Impact of comorbidity in elderly prostate cancer patients treated with brachytherapy Multidisciplinary Comprehensive Treatment of Urinary System Tumor Current clinical challenges in prostate cancer Sequence of treatment in locally advanced and metastatic renal cell carcinoma Advances in the treatment of testicular cancer Upper urinary tract disease: what we know today and unmet needs Indications for biopsy and the current status of focal therapy for renal tumours Active surveillance and focal therapy for low-intermediate risk prostate cancer Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer Mechanisms of resistance in castration-resistant prostate cancer (CRPC) Surgery and hormonal treatment for prostate cancer and sexual function Challenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapists Role of hormonal therapy for prostate cancer: perspective from Japanese experiences How to evaluate sexual health in cancer patients: development of the EORTC sexual health questionnaire for cancer patients Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors Co-constructing sexual recovery after prostate cancer: a qualitative study with couples Couples-based interventions following prostate cancer treatment: a narrative review The argument for palliative care in prostate cancer Prevention of bone metatasis in prostate cancer by denosumab: Unneeded endpoint or unmet need? Contemporary and future insights into fertility preservation in male cancer patients A second opportunity to come for anti-angiogenics in prostate cancer? Treatment of localized prostate cancer in elderly patients The primary health care physician and the cancer patient: tips and strategies for managing sexual health Future perspectives of prostate cancer therapy